HLA-DRB1 Alleles Associated with Lower Leishmaniasis Susceptibility Share Common Amino Acid Polymorphisms and Epitope Binding Repertoires
- PMID: 33803005
- PMCID: PMC8002611
- DOI: 10.3390/vaccines9030270
HLA-DRB1 Alleles Associated with Lower Leishmaniasis Susceptibility Share Common Amino Acid Polymorphisms and Epitope Binding Repertoires
Abstract
Susceptibility for leishmaniasis is largely dependent on host genetic and immune factors. Despite the previously described association of human leukocyte antigen (HLA) gene cluster variants as genetic susceptibility factors for leishmaniasis, little is known regarding the mechanisms that underpin these associations. To better understand this underlying functionality, we first collected all known leishmaniasis-associated HLA variants in a thorough literature review. Next, we aligned and compared the protection- and risk-associated HLA-DRB1 allele sequences. This identified several amino acid polymorphisms that distinguish protection- from risk-associated HLA-DRB1 alleles. Subsequently, T cell epitope binding predictions were carried out across these alleles to map the impact of these polymorphisms on the epitope binding repertoires. For these predictions, we used epitopes derived from entire proteomes of multiple Leishmania species. Epitopes binding to protection-associated HLA-DRB1 alleles shared common binding core motifs, mapping to the identified HLA-DRB1 amino acid polymorphisms. These results strongly suggest that HLA polymorphism, resulting in differential antigen presentation, affects the association between HLA and leishmaniasis disease development. Finally, we established a valuable open-access resource of putative epitopes. A set of 14 HLA-unrestricted strong-binding epitopes, conserved across species, was prioritized for further epitope discovery in the search for novel subunit-based vaccines.
Keywords: HLA association; Leishmania; antigen presentation; human leukocyte antigen; immunogenetics; immunoinformatics; leishmaniasis; vaccine candidates.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures





Similar articles
-
Epitope-Binding Characteristics for Risk versus Protective DRB1 Alleles for Visceral Leishmaniasis.J Immunol. 2018 Apr 15;200(8):2727-2737. doi: 10.4049/jimmunol.1701764. Epub 2018 Mar 5. J Immunol. 2018. PMID: 29507109 Free PMC article.
-
Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds.BMC Immunol. 2012 Dec 10;13:67. doi: 10.1186/1471-2172-13-67. BMC Immunol. 2012. PMID: 23227878 Free PMC article.
-
Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences.Arthritis Rheum. 2004 Jan;50(1):63-71. doi: 10.1002/art.11366. Arthritis Rheum. 2004. PMID: 14730600
-
Human genetics of leishmania infections.Hum Genet. 2020 Jun;139(6-7):813-819. doi: 10.1007/s00439-020-02130-w. Epub 2020 Feb 13. Hum Genet. 2020. PMID: 32055998 Free PMC article. Review.
-
Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis.Semin Arthritis Rheum. 2002 Jun;31(6):355-60. doi: 10.1053/sarh.2002.32552. Semin Arthritis Rheum. 2002. PMID: 12077707 Review.
Cited by
-
Immune response to viscerotropic Leishmania: a comprehensive review.Front Immunol. 2024 Sep 18;15:1402539. doi: 10.3389/fimmu.2024.1402539. eCollection 2024. Front Immunol. 2024. PMID: 39359727 Free PMC article. Review.
-
Multi-epitope vaccine design against leishmaniasis using IFN-γ inducing epitopes from immunodominant gp46 and gp63 proteins.J Genet Eng Biotechnol. 2024 Mar;22(1):100355. doi: 10.1016/j.jgeb.2024.100355. Epub 2024 Feb 2. J Genet Eng Biotechnol. 2024. PMID: 38494264 Free PMC article.
-
A T-Cell Epitope-Based Multi-Epitope Vaccine Designed Using Human HLA Specific T Cell Epitopes Induces a Near-Sterile Immunity against Experimental Visceral Leishmaniasis in Hamsters.Vaccines (Basel). 2021 Sep 23;9(10):1058. doi: 10.3390/vaccines9101058. Vaccines (Basel). 2021. PMID: 34696166 Free PMC article.
-
Overcoming roadblocks in the development of vaccines for leishmaniasis.Expert Rev Vaccines. 2021 Nov;20(11):1419-1430. doi: 10.1080/14760584.2021.1990043. Epub 2021 Nov 2. Expert Rev Vaccines. 2021. PMID: 34727814 Free PMC article. Review.
-
A preliminary indication that HLA-A*03:01 may be associated with visceral leishmaniasis development in people living with HIV in Ethiopia.PLoS Negl Trop Dis. 2024 Sep 30;18(9):e0012000. doi: 10.1371/journal.pntd.0012000. eCollection 2024 Sep. PLoS Negl Trop Dis. 2024. PMID: 39348450 Free PMC article.
References
-
- WHO . Surveillance of Leishmaniasis in the WHO European Region., 2016 and Global Leishmaniasis Surveillance Update, 1998–2016. Volume 40. WHO; Geneva, Switzerland: 2018. pp. 521–540.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials